French biotech OSE Immunotherapeutics has reported positive topline Phase II data for its cancer vaccine Tedopi in recurrent ovarian cancer, but the clinical signal is most clearly seen in combination with MSD’s anti-PD-1 antibody Keytruda.
Tag Archive for: Cancer Immunotherapies
German researchers have tracked down the causes for central nervous system side effects of cancer immunotherapies and blocked them in small animal models.